CD120a Recombinant Protein from ProteoGenix; catalogue PX-P4100; research use only.
Know who made it. See the evidence. Buy through one marketplace.
CD120a Recombinant Protein is a type I transmembrane glycoprotein, also known as tumor necrosis factor receptor (TNFR). It is composed of an extracellular domain, a transmembrane domain, and an intracellular domain.
ActivityCD120a is an antibody-drug target for the treatment of various diseases, such as autoimmunity, cancer, and chronic inflammation. It is involved in the regulation of cytokine proteins, including TNF, which are involved in inflammation and immune response.
ApplicationCD120a Recombinant Protein is used in research and drug development for the treatment of various diseases. It can be used to study the structure and function of the TNFR and to develop drugs that target this receptor. Additionally, it can be used to study the mechanism of action of cytokines and their role in inflammation and immunity.
ProteoGenix catalogue number PX-P4100. For research use only.
Host: Mammalian cells; Expression system: Eukaryotic expression; Purity: >90% by SDS-PAGE; Molecular weight: 30kDa; Tag: C-terminal His Tag; Fragment: Met1~Thr211; Buffer: PBS pH7.5; Applications: ELISA, WB.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
